Autophagy Induction via Vamana Karma (Therapeutic Emesis) in Refractory Metabolic Disorders: A Cellular and Neuro-Ayurvedic Mechanistic Synthesis

Abstract

Refractory metabolic disorders, including Type 2 Diabetes Mellitus, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and advanced obesity, are characterized at the cellular level by a systemic failure of macroautophagy. This defect leads to the uncontrolled accumulation of dysfunctional mitochondria, misfolded proteins, and ectopic lipid droplets, driving chronic low-grade inflammation and cellular insulin resistance. While mainstream medicine emphasizes ongoing pharmaceutical maintenance, traditional Ayurveda targets the elimination of deep-seated metabolic wastes (Ama and vitiated Kapha-Medas) through Vamana Karma (therapeutic emesis)—the primary bio-purificatory procedure of Panchakarma. This paper provides a comprehensive, multi-disciplinary analysis of Vamana Karma, proposing that its systematic process acts as a powerful non-pharmacological trigger for systemic autophagy induction. By tracing the physiological shifts during the three stages of Vamana—pre-operative lipid loading (Snehapana), acute neuro-endocrine activation, and intense mechanical stress—this framework connects traditional concepts of metabolic clearing (Srotoshodhana) with cellular recycling pathways. We review clinical and biochemical evidence showing that Vamana Karma dramatically downregulates mTORC1, activates the AMPK pathway, and increases key autophagic markers, such as LC3-II and Beclin-1. This alignment of classical Shodhana therapy with modern molecular biology offers an innovative approach to resetting metabolic cellular health and managing treatment resistant metabolic diseases. 

KEYWORDS: Vamana Karma, Panchakarma, Autophagy Induction, Refractory Metabolic Disorders, AMPK Activation, Ama, Srotoshodhana, Lipophagy.